Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
about
Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic reviewThe association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanismsDiabetes and cancer: a consensus report.Association of angiotensin-converting enzyme inhibitor therapy and comorbidity in diabetes: results from the Vermont diabetes information systemLatest insights into the risk of cancer in diabetesCancer biology in diabetes.Diabetes and cancer II: role of diabetes medications and influence of shared risk factors.Pioglitazone and risk of bladder cancer: a meta-analysis of controlled studies.The complexities of obesity and diabetes with the development and progression of pancreatic cancer.Cohort study of pioglitazone and cancer incidence in patients with diabetesDiabetes and risk of bladder cancer: evidence from a case-control study in New EnglandNutraceuticals as Ligands of PPARγChemotherapeutic drugs induce PPAR-gamma expression and show sequence-specific synergy with PPAR-gamma ligands in inhibition of non-small cell lung cancerPPARgamma and MEK Interactions in CancerRosiglitazone and risk of cancer: a meta-analysis of randomized clinical trialsPPAR Ligands as Potential Modifiers of Breast Carcinoma Outcomes.Inflammation and lung carcinogenesis: applying findings in prevention and treatment.Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production.Thiazolidinediones as anti-cancer agents.Clinical Use of PPARgamma Ligands in Cancer.PTEN in brain tumors.PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis.Pioglitazone: side effect and safety profile.Obesity, Diabetes and Cancer: A Mechanistic PerspectiveModern approach to metabolic rehabilitation of cancer patients: biguanides (phenformin and metformin) and beyond.Insulin resistance: pathophysiology and rationale for treatment.Do antidiabetic medications play a specific role in differentiated thyroid cancer compared to other cancer types?Diabetes mellitus: influences on cancer risk.Antihyperglycaemic therapies and cancer risk.The multifaceted factor peroxisome proliferator-activated receptor γ (PPARγ) in metabolism, immunity, and cancer.A population-based cohort study in Taiwan--use of insulin sensitizers can decrease cancer risk in diabetic patients?Use of statins offsets insulin-related cancer risk.Diabetes and its link with cancer: providing the fuel and spark to launch an aggressive growth regime.Late-onset rosiglitazone-associated acute liver failure in a patient with Hodgkin's lymphoma.Ten-year observational follow-up of PROactive: a randomized cardiovascular outcomes trial evaluating pioglitazone in type 2 diabetes.New target genes for the peroxisome proliferator-activated receptor-γ (PPARγ) antitumour activity: Perspectives from the insulin receptorMetformin and cancer: licence to heal?Dose effect of thiazolidinedione on cancer risk in type 2 diabetes mellitus patients: a six-year population-based cohort study.Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.The safety of rosiglitazone in the treatment of Type 2 diabetes
P2860
Q26850912-CD01493E-A6AD-4681-9D81-61647771C8CFQ27026813-8D7895DC-FDD1-4893-8CE4-DE173294974CQ27686977-2184898F-DACA-46C2-86A8-1104CECDC462Q33390497-5041F84C-607F-4516-A854-0300037F38EAQ33588852-4393E5B6-8DB6-45E9-B556-3AACCFC47418Q33608038-5AC86CC3-962C-4752-AE95-9D0023034FB9Q34069086-D816BC6B-4084-4C47-B51D-94CCEBB1B62CQ34324440-0082AA7C-7B6D-4248-AE7D-5BD919DE42EFQ34669361-FFA597F1-08A5-476C-A886-B5E5BF9D13D3Q34718437-C785AA58-948A-4D36-94E4-C95759B20E3FQ35051024-5B217E33-CF1F-4FF7-A45B-FC6F7B2C5594Q36072211-B527DCBD-B479-465B-993F-EEF65516569CQ36661722-1FCE3B89-5E4A-491E-9E26-1CF0E3C4261CQ36737285-F3245C83-D891-4DCE-8131-B912757824D8Q36756632-71D755F4-AC3F-442C-B296-A51631C61FC0Q36772391-17364CB5-C6AB-41F2-AACC-5B252C7C7034Q36974700-27172C04-EC29-45F3-83EC-446A577D9A56Q36976999-759F9BA4-778B-4884-8290-53063E5DA264Q37010188-136D3040-CF4D-4A3B-88A5-3B93F9BFE1B0Q37021288-8C839C67-23B4-4CB0-A115-FBAA258AE071Q37139779-DA0C1132-2284-4CA8-AFF3-45F570AE4240Q37656960-D8AED0D1-A8E9-4A16-A2D3-A229CF273F04Q37696508-A39F995A-E56D-4528-BBCA-A02D35FB7A42Q37730336-6E943D12-57B4-4816-9173-5B51635653C4Q37783621-5FECFAE5-2590-4C69-B80B-DB209B1AFDD2Q37838172-DEE33B21-5AE8-42CC-8A21-A00E72F5A163Q37924944-9C5DE44F-9B0E-4C8F-BE0D-4E849366AF61Q38232006-3B3A3772-960C-429C-95FC-CB83FB59261CQ38250719-03124E3D-66B6-4D4B-82E4-1F8CA521DD50Q38314756-2819C7A9-C2BA-4363-A56E-2699109C4E42Q38429541-363DDC32-1655-4D1F-BE99-D583B73293E6Q39263827-8A967013-E2BB-4DE1-9100-BB83910C7016Q40037417-B9553E11-0400-4ECC-B4D4-96ECDA46341BQ40422366-F7B1DBE6-15E2-4639-BA45-98E8330C3EF7Q41107308-19F9A9C9-9910-4D13-BE39-20BC355ADDC7Q42167608-6E230AA0-3F9B-489D-ABD7-4A4FE10AE69AQ43015031-4B5E9DDE-016A-4991-AC54-0884C72E0EA0Q53060957-A7168849-1904-4D71-B969-35681C43CB26Q54649308-9C1931C1-11E0-453A-961F-2F7920F93DECQ57413490-751546DB-9E46-4203-92F5-551F89A040F5
P2860
Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Association between cancer pre ...... nt Diabetes Information System
@ast
Association between cancer pre ...... nt Diabetes Information System
@en
type
label
Association between cancer pre ...... nt Diabetes Information System
@ast
Association between cancer pre ...... nt Diabetes Information System
@en
prefLabel
Association between cancer pre ...... nt Diabetes Information System
@ast
Association between cancer pre ...... nt Diabetes Information System
@en
P2860
P356
P1433
P1476
Association between cancer pre ...... nt Diabetes Information System
@en
P2093
Charles D MacLean
Maria E Ramos-Nino
P2860
P2888
P356
10.1186/1741-7015-5-17
P407
P577
2007-06-21T00:00:00Z
P5875
P6179
1031605719